Michael King is currently the Head of the Neuropsychiatry and Movement Disorders Unit at Biogen, a position held since 2024. Their extensive experience in the pharmaceutical industry includes roles as Director of Clinical Exploratory Pharmacology and Senior Director, Diabetes Project Leader at Sanofi, where they have been employed since 2007. From 2001 to 2007, they served as Associate Director of Experimental Medicine at Johnson & Johnson Pharmaceutical Research and Development. Earlier in their career, Michael worked as a Research Associate at Memorial Sloan-Kettering Cancer Center from 1996 to 2001. They earned a Ph.D. in Pharmacology with a focus on Neuropharmacology from Kent State University and an MHSc in Clinical Research from Duke University School of Medicine.
This person is not in any teams
This person is not in any offices